Thursday Lunch Symposium

Vaginitis is one of the most common reasons for primary care visits among women with a gynecologic-related diagnosis in the United States (US). We will describe real-world diagnostic testing, healthcare resource utilization (HCRU), and treatment patterns of people presenting with vaginitis symptoms in the US, followed by analysis of whether diagnostic testing is associated with subsequent HCRU and treatment. Additionally, we will present an economic analysis that evaluates the costs and outcomes associated with a CLIA-waived molecular diagnostic test compared to laboratory-based molecular tests.